FCM
CORZ icon

Fourpath Capital Management’s Core Scientific CORZ Stock Holding History

Fourpath Capital Management’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-90
Closed -$1.07K – 350
2024
Q3 		$1.07K Buy
+90
New +$933 ﹤0.01% 697

Other funds holding CORZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GC
Gullane Capital Memphis, Tennessee $37.4M AUM 112.18% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
OWP
ORG Wealth Partners Dallas, Texas $508M AUM 83.62% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
HPM
Helix Partners Management New York $374M AUM 136.73% 1-Year Est. Return
JCM
JAT Capital Management Greenwich, Connecticut $59.3M AUM 134.04% 1-Year Est. Return

Fourpath Capital Management's CORZ Position: Q4 2024 in Review

Fourpath Capital Management sold out of Core Scientific (CORZ) in Q4 2024, closing a stake of 90 shares — an estimated $1.07K sold.

Fourpath Capital Management first reported a position in CORZ in Q3 2024 and held it in 1 quarter. The position peaked at $1.07K in Q3 2024. 313 funds tracked by Wall St. Rank hold CORZ as of Q4 2024.

  • Fourpath Capital Management reported no remaining Core Scientific position as of Q4 2024 after selling out during the quarter.
  • Fourpath Capital Management sold 90 Core Scientific shares in Q4 2024, an estimated $1.07K.
  • Fourpath Capital Management first reported a position in Core Scientific in Q3 2024 and held it in 1 quarter.
  • Fourpath Capital Management's Core Scientific position peaked at $1.07K in Q3 2024.
  • 313 funds tracked by Wall St. Rank held Core Scientific as of Q4 2024.

Based on Fourpath Capital Management's 13F filing for Q4 2024, filed 24 Jan 2025.